This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Stock Offerings: Funtalk China

BOSTON (TheStreet) -- Funtalk China (FTLK) shares fell at the start of trading Tuesday after the company announced a public offering of common shares.

Funtalk China said it intends to offer 10.39 million ordinary shares in a public offering, with proceeds to be used to expand its retail network. underwriters will have an option to purchase up to an additional 1.55 million ordinary shares, the company said.

In addition, selling shareholders intend to offer approximately 1.61 million ordinary shares of Funtalk China, although the company will not see any proceeds from any offering by shareholders.

Funtalk China shares were lately down 2 cents, or 0.3%, to $6.89. The stock touched an intraday low of $6.50 earlier in the session.

Elsewhere, Vantage Drilling (VTG) said it intends to offer $50 million of ordinary shares, and that underwriters of the offering have the option to purchase an additional $7.5 million of ordinary shares to cover overallotments. Concurrently, Vantage's subsidiary Offshore Group Investment will offer $960 million in senior secured notes due 2015.

Vantage said the consummation of the public offering of common shares is conditioned upon the closing of Offshore's note offering and the closing of Vantage's previously announced acquisition of the 55% interest in Mandarin Drilling. Net proceeds from the concurrent offerings will be used to fund the acquisition, with the remainder to be used to repay debt and for remaining construction payments.

Vantage Drilling shares were falling by 6 cents, or 5.1%, to $1.03. Earlier in Tuesday's trading session the stock fell to a new 52-week low of 99 cents.

Additionally, PharmAthene (PIP) said it will sell $3.9 million of its common stock and warrants to an existing institutional investor through a registered direct offering.

PharmAthene said it will sell approximately 2.78 million newly issued shares of its common stock at $1.40 per share and warrants to purchase about 1.32 million shares of its common stock at an exercise price of $1.63 per share.

PharmAthene shares fell by 11 cents, or 6.8%, to $1.52.

-- Written by Robert Holmes in Boston.

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,979.13 +59.54 0.35%
S&P 500 1,986.51 +4.91 0.25%
NASDAQ 4,526.4820 -1.0320 -0.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs